Lista de obras - Lei Jin - Dominio Público Uruguay

A p53-responsive microRNA network promotes cancer cell quiescence

artículo científico publicado en 2018

ACTN4 regulates the stability of RIPK1 in melanoma.

artículo científico publicado en 2018

AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanoma

artículo científico publicado en 2013

Adipocytes contribute to resistance of human melanoma cells to chemotherapy and targeted therapy.

artículo científico

BAG3-dependent expression of Mcl-1 confers resistance of mutant KRAS colon cancer cells to the HSP90 inhibitor AUY922.

artículo científico publicado en 2017

BRAF/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanoma

artículo científico publicado en 2017

Cooperativity of HOXA5 and STAT3 is critical for HDAC8 inhibition-mediated transcriptional activation of PD-L1 in human melanoma cells.

artículo científico publicado en 2017

Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3.

artículo científico publicado en 2013

Dual functions for OVAAL in initiation of RAF/MEK/ERK prosurvival signals and evasion of p27-mediated cellular senescence

article published in the Proceedings of the National Academy of Sciences of the United States of America

E2F1 represses beta-catenin/TCF activity by direct up-regulation of Siah1.

artículo científico

Endoplasmic reticulum stress inhibits cell cycle progression via induction of p27 in melanoma cells.

artículo científico publicado en 2012

GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability.

artículo científico publicado en 2018

Histone deacetylases (HDACs) as mediators of resistance to apoptosis in melanoma and as targets for combination therapy with selective BRAF inhibitors.

artículo científico publicado en 2012

INPP4B is an oncogenic regulator in human colon cancer.

artículo científico publicado en 2015

INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas.

artículo científico publicado en 2015

Inhibition of HSP90 by AUY922 Preferentially Kills Mutant KRAS Colon Cancer Cells by Activating Bim through ER Stress.

artículo científico publicado en 2016

Involvement of vacuolar H(+)-ATPase in killing of human melanoma cells by the sphingosine kinase analogue FTY720.

artículo científico publicado en 2014

LncRNA IDH1-AS1 links the functions of c-Myc and HIF1α via IDH1 to regulate the Warburg effect.

artículo científico publicado en 2018

Loss of PI(4,5)P2 5-Phosphatase A Contributes to Resistance of Human Melanoma Cells to RAF/MEK Inhibitors.

artículo científico publicado en 2013

MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma

artículo científico publicado en 2011

MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer

artículo científico publicado en 2012

MicroRNA-645 is an oncogenic regulator in colon cancer.

artículo científico publicado en 2017

Oncogenic activation of MEK/ERK primes melanoma cells for adaptation to endoplasmic reticulum stress.

artículo científico publicado en 2013

Oncogenic suppression of PHLPP1 in human melanoma

artículo científico publicado en 2013

Phenotypic characterization and risk factors for microtia in East China, a case-control study.

artículo científico publicado en 2014

RIP1 Kinase Is an Oncogenic Driver in Melanoma.

artículo científico publicado en 2015

RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors.

artículo científico publicado en 2018

RIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagy.

artículo científico publicado en 2015

Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922

artículo científico publicado en 2016

Reactive Oxygen Species Dictate the Apoptotic Response of Melanoma Cells to TH588.

artículo científico publicado en 2016

Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF)

artículo científico publicado en 2011

Regulation of PD-L1: a novel role of pro-survival signalling in cancer.

artículo científico

Skp2-Mediated Stabilization of MTH1 Promotes Survival of Melanoma Cells upon Oxidative Stress.

artículo científico publicado en 2017

Suppression of PP2A is critical for protection of melanoma cells upon endoplasmic reticulum stress ⬇️

artículo científico publicado el 28 de junio de 2012

Sustained IRE1 and ATF6 signaling is important for survival of melanoma cells undergoing ER stress

artículo científico publicado en 2013

Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis

artículo científico publicado en 2020

The double life of RIPK1.

artículo científico publicado en 2015

The epigenetic regulator I-BET151 induces BIM-dependent apoptosis and cell cycle arrest of human melanoma cells.

artículo científico publicado en 2014

The melanoma-associated antigen MAGE-D2 suppresses TRAIL receptor 2 and protects against TRAIL-induced apoptosis in human melanoma cells.

artículo científico publicado en 2012

c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis

artículo científico publicado en 2020

p53-facilitated miR-199a-3p regulates somatic cell reprogramming.

artículo científico publicado en 2012

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

artículo científico publicado en 2016

Lista de obras de Lei Jin

A p53-responsive microRNA network promotes cancer cell quiescence

ACTN4 regulates the stability of RIPK1 in melanoma.

AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanoma

Adipocytes contribute to resistance of human melanoma cells to chemotherapy and targeted therapy.

BAG3-dependent expression of Mcl-1 confers resistance of mutant KRAS colon cancer cells to the HSP90 inhibitor AUY922.

BRAF/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanoma

Cooperativity of HOXA5 and STAT3 is critical for HDAC8 inhibition-mediated transcriptional activation of PD-L1 in human melanoma cells.

Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3.

Dual functions for OVAAL in initiation of RAF/MEK/ERK prosurvival signals and evasion of p27-mediated cellular senescence

E2F1 represses beta-catenin/TCF activity by direct up-regulation of Siah1.

Endoplasmic reticulum stress inhibits cell cycle progression via induction of p27 in melanoma cells.

GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability.

Histone deacetylases (HDACs) as mediators of resistance to apoptosis in melanoma and as targets for combination therapy with selective BRAF inhibitors.

INPP4B is an oncogenic regulator in human colon cancer.

INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas.

Inhibition of HSP90 by AUY922 Preferentially Kills Mutant KRAS Colon Cancer Cells by Activating Bim through ER Stress.

Involvement of vacuolar H(+)-ATPase in killing of human melanoma cells by the sphingosine kinase analogue FTY720.

LncRNA IDH1-AS1 links the functions of c-Myc and HIF1α via IDH1 to regulate the Warburg effect.

Loss of PI(4,5)P2 5-Phosphatase A Contributes to Resistance of Human Melanoma Cells to RAF/MEK Inhibitors.

MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma

MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer

MicroRNA-645 is an oncogenic regulator in colon cancer.

Oncogenic activation of MEK/ERK primes melanoma cells for adaptation to endoplasmic reticulum stress.

Oncogenic suppression of PHLPP1 in human melanoma

Phenotypic characterization and risk factors for microtia in East China, a case-control study.

RIP1 Kinase Is an Oncogenic Driver in Melanoma.

RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors.

RIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagy.

Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922

Reactive Oxygen Species Dictate the Apoptotic Response of Melanoma Cells to TH588.

Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF)

Regulation of PD-L1: a novel role of pro-survival signalling in cancer.

Skp2-Mediated Stabilization of MTH1 Promotes Survival of Melanoma Cells upon Oxidative Stress.

Suppression of PP2A is critical for protection of melanoma cells upon endoplasmic reticulum stress ⬇️

Sustained IRE1 and ATF6 signaling is important for survival of melanoma cells undergoing ER stress

Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis

The double life of RIPK1.

The epigenetic regulator I-BET151 induces BIM-dependent apoptosis and cell cycle arrest of human melanoma cells.

The melanoma-associated antigen MAGE-D2 suppresses TRAIL receptor 2 and protects against TRAIL-induced apoptosis in human melanoma cells.

c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis

p53-facilitated miR-199a-3p regulates somatic cell reprogramming.

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)